Qianguan Pharmaceutical: Yu Junxian and others plan to reduce their holdings by 0.1718% in 3 months.

Qianyuan Pharmaceutical Announcement: Director and Vice President Yu Junxian, senior executives Gu Baoping, Yu Yingmin, He Yanjie, Luo Kairui plan to reduce their holdings by no more than 289,200 shares, 43,700 shares, 43,700 shares, 25,000 shares, 25,000 shares respectively through centralized bidding or block trading within 3 months after the disclosure date of 15 trading days, accounting for 0.1165%, 0.0176%, 0.0176%, 0.0101%, 0.0101% of the company's total share capital, totaling no more than 426,600 shares, accounting for 0.1718% of the company's total share capital.